Recipharm and LIDDS Establish Industrial Manufacturing Capabilities for Prostate Cancer Drug
PTSM: Pharmaceutical Technology Sourcing and Management
ipharm set up a manufacturing line at its facility in Sweden using LIDD’s NanoZolid technology.
Recipharm, a contract development and manufacturing organization (CDMO), and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, which contains 2-hydroxyflutamide, at Recipharm’s facility in Solna, Sweden.
The manufacturing line is dedicated to the first product based on LIDDS’ innovative NanoZolid technology, which provides localized controlled release that can be sustained for up to six months. NanoZolid can integrate both small- and large-molecule drugs. Clinical trial material has already been produced, and the facility is ready for future commercial manufacturing of Liproca Depot or other pharmaceutical formulations based on the NanoZolid technology. The manufacturing line has been adapted for GMP production and uses a unique process invented by LIDDS that uses equipment that is new to the pharmaceutical industry.
”With the successful manufacturing performed at Recipharm, LIDDS can offer license agreements for Liproca Depot with the advantage of having validated production in place, saving both time and money for pharma companies. In addition, we now have an established manufacturing facility ready for other NanoZolid projects,” says Monica Wallter CEO of LIDDS.
Source: Recipharm
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
